Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Alshreef%2C+Abualbishr%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Alshreef%2C+Abualbishr%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Alshreef%2C+Abualbishr%22&type=Person&sort=year
PubPharm (30)
1
Correction to : Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
enthalten in:
PharmacoEconomics
| 2021
von
Pennington, B.
|
Alshreef, A.
|
Flight, L.
| +12
ErratumFor: Pharmacoeconomics. 2021 Aug;39(8):913-927. - PMID 33900585
Wird geladen...
2
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion : The LEAVO Study
enthalten in:
PharmacoEconomics
| 2021
von
Pennington, B.
|
Alshreef, A.
|
Flight, L.
| +12
ErratumIn: Pharmacoeconomics. 2021 Jun 19;:. - PMID 34148190
Wird geladen...
3
Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
enthalten in:
PharmacoEconomics
| 2021
von
Pennington, B.
|
Alshreef, A.
|
Flight, L.
| +12
Wird geladen...
4
Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
enthalten in:
PharmacoEconomics
| 2021
von
Pennington, B.
|
Alshreef, A.
|
Flight, L.
| +12
Wird geladen...
5
Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
enthalten in:
PharmacoEconomics
| 2021
von
Pennington, B.
|
Alshreef, A.
|
Flight, L.
| +12
Wird geladen...
6
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion : the LEAVO non-inferiority three-arm RCT
enthalten in:
Health technology assessment (Winchester, England)
| 2021
von
Hykin, P.
|
Prevost, A.
|
Sivaprasad, S.
| +16
Wird geladen...
7
Self-managed, computerised word finding therapy as an add-on to usual care for chronic aphasia post-stroke : An economic evaluation
enthalten in:
Clinical rehabilitation
| 2021
von
Latimer, N.
|
Bhadhuri, A.
|
Alshreef, A.
| +10
Wird geladen...
8
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
enthalten in:
PharmacoEconomics
| 2021
von
Pennington, B.
|
Alshreef, A.
|
Flight, L.
| +12
Wird geladen...
9
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
enthalten in:
PharmacoEconomics
| 2021
von
Pennington, B.
|
Alshreef, A.
|
Flight, L.
| +12
Wird geladen...
10
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
enthalten in:
PharmacoEconomics
| 2021
von
Pennington, B.
|
Alshreef, A.
|
Flight, L.
| +12
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
30
Aufsätze
26
E-Artikel
26
E-Ressourcen
4
Gedruckte Aufsätze
Zeitschriftentitel
8
PharmacoEconomics
3
BMC family practice
3
Health technology assessment (Winchester, England)
3
Pilot and feasibility studies
2
Applied health economics and health policy
2
PharmacoEconomics - open
2
The lancet <London>
1
Clinical rehabilitation
1
Lancet (London, England)
1
Medical decision making : an international jour...
1
Physiotherapy
1
The Lancet. Neurology
1
Value in health : the journal of the Internatio...
1
Value in health regional issues
Alle anzeigen ...
weniger ...
Thema
14
Journal Article
10
Randomized Controlled Trial
9
Research Support, Non-U.S. Gov't
6
Type 2 diabetes
3
15C2VL427D
3
2S9ZZM9Q9V
3
Angiogenesis Inhibitors
3
Bevacizumab
3
Cluster randomised trial
3
Comparative Study
3
Diabetes education
3
Diabetes self-management
3
EC 2.7.10.1
3
Feasibility study
3
Multicenter Study
3
National Health Service
3
Randomised controlled trial
3
Ranibizumab
3
Receptors, Vascular Endothelial Growth Factor
3
Recombinant Fusion Proteins
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
15
2020-
15
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
30
Englisch
Haven't found what you're looking for?
Wird geladen...